Our total non-GAAP combined R&D and SG&A expenses of $1.7 billion was below the low end of our guidance range, including savings in marketing and travel expenses.

Apr 29, 2020 / CFO / receipt, needs a key / Akash Balkhawala, CFO | earnings call 2020-04-29 | transcript 24d9114a-cd6f-44ae-9306-33f9f2391ad1 | chars 8338-8500 | segment 8